High consumption of smokeless tobacco (“snus”) predicts increased risk of type 2 diabetes in a 10-year prospective study of middle-aged Swedish men

Scandinavian Journal of Public Health

Volumn 40, Issue 8, 2012, Pages 730-737

  Östenson, Claes Göran ^a   Hilding, Agneta ^a   Efendic, Suad ^a   Grill, Valdemar ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Harm reduction; oral moist snuff; prediction; tobacco; type 2 diabetes

Indexed keywords

ADULT; ARTICLE; FOLLOW UP; GLUCOSE TOLERANCE TEST; HUMAN; INCIDENCE; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSPECTIVE STUDY; RISK; RISK ASSESSMENT; SMOKELESS TOBACCO; SWEDEN;

ADULT; DIABETES MELLITUS, TYPE 2; FOLLOW-UP STUDIES; GLUCOSE TOLERANCE TEST; HUMANS; INCIDENCE; MALE; MIDDLE AGED; ODDS RATIO; PROSPECTIVE STUDIES; RISK ASSESSMENT; SWEDEN; TOBACCO, SMOKELESS;

EID: 84870582338     PISSN: 14034948     EISSN: 16511905     Source Type: Journal    
DOI: 10.1177/1403494812459814     Document Type: Article

References (30)

1. Wild S. Roglic G. Green A. Sicree R. King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047–53.
2. McCarthy M.I. Froguel P. Genetic approaches to the molecular understanding of type 2 diabetes. Am J Physiol Endocrinol Metab 2002;283:E217–E225.
3. Hamman R. Genetic and environmental determinants of non-insulin-dependent diabetes mellitus (NIDDM). Diabetes Metab Rev 1992;8:287–338.
4. Rimm E.B. Manson J.E. Stampfer M.J. Colditz G.A. Willett W.C. Rosner B. et al. Cigarette smoking and the risk of diabetes in women. Am J Public Health 1993;83:211–14.
5. Kawakami N. Takatsuka N. Shimizu H. Ishibashi H. Effects of smoking on the incidence of non-insulin-dependent diabetes mellitus. Replication and extension in a Japanese cohort of male employees. Am J Epidemiol 1997;145:103–9.
6. Manson J.E. Ajani U.A. Liu S. Nathan D.M. Hennekens C.H. A prospective study of cigarette smoking and the incidence of diabetes mellitus among US male physicians. Am J Med 2000;109:538–42.
7. Will J.C. Galuska D.A. Ford E.S. Mokdad A. Calle E.E. Cigarette smoking and diabetes mellitus: evidence of a positive association from a large prospective cohort study. Int J Epidemiol 2001;30:540–6.
8. Persson P.G. Carlsson S. Svanström L. Östenson C.G. Efendic S. Grill V. Cigarette smoking, oral moist snuff use and glucose intolerance. J Intern Med 2000;248:103–10.
9. Rodu B. Stegmayr B. Nasic S. Asplund K. Impact of smokeless tobacco use on smoking in northern Sweden. J Intern Med 2002;252:398–404.
10. Shields P.G. Tobacco smoking, harm reduction, and biomarkers. J Natl Cancer Inst 2002;94:1435–44.
11. Gilljam H. Galanti R. Role of snus (oral moist snuff) in smoking cessation and smoking reduction in Sweden. Addiction 2003;98:1183–9.
12. Britton J. Smokeless tobacco: friend or foe? Addiction 2003;98:1199–201.
13. Hatsukami D.K. Lemmonds C. Tomar S.L. Smokeless tobacco use: harm reduction or induction of approach? Prev Med 2004;38:309–17.
14. Roth H.D. Roth A.B. Liu X. Health risks of smoking compared to Swedish snus. Inhal Toxicol 2005;17:741–8.
15. Levy D.T. Mumford E.A. Cummings K.M. Gilpin E.A. Giovino G.A. Hyland A. et al. The potential impact of a low–nitrosamine smokeless tobacco product on cigarette smoking in the United States: estimates of a panel of experts. Addict Behav 2006;31:1190–200.
16. Asplund K. Smokeless tobacco and cardiovascular disease. Prog Cardiovasc Dis 2003;45:383–94.
17. Bolinder G.M. Ahlborg B.O. Lindell J.H. Use of smokeless tobacco: blood pressure elevation and other health hazards found in a large-scale population survey. J Intern Med 1992;232:327–34.
18. Eliasson M. Asplund K. Nasic S. et al. Influence of smoking and snus on the prevalence of type 2 diabetes amongst men: the northern Sweden MONICA study. J Intern Med 2004;256:101–10.
19. Lee P.N. Summary of the epidemiological evidence relating snus to health. Regul Toxicol Pharmacol 2011;59:197–214.
20. Eriksson A.K. Ekbom A. Granath F. Hilding A. Efendic S. Östenson C.G. Psychological distress and risk of pre-diabetes and type 2 diabetes in a prospective study of Swedish middle-aged men and women. Diabet Med 2008;25:834–42.
21. Yoshikawa H. Hellström-Lindahl E. Grill V. Evidence for functional nicotinic receptors on pancreatic β cells. Metabolism Clin Exp 2005;54:247–54.
22. Eliasson B. Cigarette smoking and diabetes. Prog Cardiovasc Dis 2003;45:405–13.
23. Östgren C.J. Lindblad U. Ranstam J. Melander A. Råstam L. Associations between smoking and beta-cell function in a non-hypertensive and non-diabetic population. Diabet Med 2000;17:445–50.
24. Chiolero A. Faeh D. Paccaud F. Cornuz J. Consequences of smoking for body weight, body fat distribution, and insulin resistance. Am J Clin Nutr 2008;87:801–9.
25. Berlin I. Smoking-induced metabolic disorders: a review. Diabetes Metab 2008;34:307–14.
26. Fagerström K. The nicotine market: an attempt to estimate the nicotine intake from various sources and the total nicotine consumption in some countries. Nicotine Tobacco Res 2005;7:343–50.
27. Carlsson S. Persson Brobert G.P. Grill V. Influence of smoking and snus on the prevalence and incidence of type 2 diabetes amongst men: the northern Sweden MONICA study. J Intern Med 2005;257:481–2.
28. Eliasson M. Nasic S. Rodu B. In reply to “Influence of smoking and snus on the prevalence and incidence of type 2 diabetes amongst men: the northern Sweden MONICA”. J Intern Med 2005;257:483.
29. Norberg M. Stenlund H. Lindahl B. Boman K. Weinehall L. Contribution of Swedish moist snuff to the metabolic syndrome: a wolf in sheep's clothing? Scand J Public Health 2006;34:576–83.
30. Yeager D.S. Krosnick J.A. The validity of self-reported nicotine product use in the 2001-2008 National Health and Nutrition Examination Survey. Med Care 2010;48;1128–32.